The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of https://bookmarkboom.com/story21384387/copyright-s-pill-and-big-pharma-a-uncertain-opportunity